The risk groups for preventive medication against RSV have been confirmed
In Finland, nirsevimab will be offered to all children born during the 2024-2025 winter RSV epidemic and to those under three months of age when the epidemic starts.
Europe’s top young musicians join forces with healthcare and technology pioneers in Turku
For over twenty years, Prof. emer. Seppo Soinila has been leading pioneering research at Turku University Hospital into music’s contribution to healing injured brains. Soinila’s group has been affiliated into Academy of Finland Centre of Excellence in Music, Mind, Body and Brain.
